Tamsulosin (Urimax) In Female Patient: A Case of Recurrent UTI and Left Pelvic Calculi
Tamsulosin hydrochloride is a selective α1A-adrenergic receptor antagonist commonly used in the treatment of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that can impede normal urinary flow in men. By selectively blocking α1A receptors predominantly located in the smooth muscle of the prostate and bladder neck, tamsulosin relaxes these muscles, thereby improving urine flow and reducing symptoms of urinary obstruction. Administered orally, typically in extended-release formulations, tamsulosin is well-tolerated, with common side effects including dizziness, abnormal ejaculation, and rhinitis. It is metabolized primarily by the liver via cytochrome P450 enzymes and excreted in the urine. By relaxing the smooth muscles in the urethral and bladder neck, tamsulosin can be used off-label to treat voiding dysfunctions in females, such as LUTS (Lower urinary tract symptoms), BOO (Bladder outlet obstruction), or urinary retention. It should be used on an individual basis and is frequently saved for particular situations when there aren't many other options.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-09-27
- DOI
- https://doi.org/10.5281/zenodo.17212097
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00